Published August, 2016
By Masahiro Kizaki
Publisher: Springer (Springer Verlag, Japan)
Rating:
Availability: Available
By Masahiro Kizaki
Publisher: Springer (Springer Verlag, Japan)
Rating:
Availability: Available
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia provides a comprehensive understanding of the recent molecular genetics of Chronic Myelogenous Leukemia (CML) and a characterization of the molecular targets for drug development.
Paperback / softback
€131.76
Published August, 2016
By John E. Morley, Giovanni Mantovani, Stefan D. Anker, Akio Inui, Filippo Rossi Fanelli, Daniele Scevola, Michael W. Schuster and Shing-Shing Yeh
Publisher: Springer (Springer Verlag)
Rating:
Availability: Available
By John E. Morley, Giovanni Mantovani, Stefan D. Anker, Akio Inui, Filippo Rossi Fanelli, Daniele Scevola, Michael W. Schuster and Shing-Shing Yeh
Publisher: Springer (Springer Verlag)
Rating:
Availability: Available
Paperback / softback
€365.99
Published August, 2016
By Ross Levine, Sharon Gerecht, Cynthia Reinhart-King, Paul Janmey, Daniel Fletcher, Parag Mallick, Owen McCarty and Lance Munn
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available
By Ross Levine, Sharon Gerecht, Cynthia Reinhart-King, Paul Janmey, Daniel Fletcher, Parag Mallick, Owen McCarty and Lance Munn
Publisher: Springer (Springer International Publishing AG)
Rating:
Availability: Available
The study was sponsored by the National Cancer Institute (NCI) at the National Institute of Health (NIH), the National Science Foundation (NSF) and the National Institute of Biomedical Imaging and Bioengineering at the NIH in the US under a cooperative agreement with the World Technology Evaluation Center (WTEC).
Paperback / softback
€121.99
Adding to a vitally important cycle of publications covering the latest research developments in our understanding of neoplasms affecting the human central nervous system, this edition focuses on numerous aspects of pineal, pituitary, and spinal tumors.
Paperback / softback
€255.59
This fourteenth volume of the series provides comprehensive, current information on the diagnosis, therapy and prognosis of brain tumors and spinal tumors. For the readers' convenience, contributions are organized into three categories of Pineal Tumors, Pituitary Tumors, and Spinal Tumors.
Paperback / softback
€121.99
Paperback / softback
€134.19
A general introduction to the principles of diagnosis and treatment of children with brain tumors is presented. Also are detailed results of clinical trials in pediatric brain tumors, such as medulloblastoma, ependymoma, craniopharyngioma, low-grade glioma, high-grade glioma, brainstem glioma, and germ cell tumors, using radiotherapy.
Paperback / softback
€182.99
With much more besides, including discussion of the molecular mechanisms that result in resistance to chemotherapy in medulloblastoma, this volume and its companions have a positive role to play in inspiring a new generation of researchers to design new drugs that are better targeted-and thus more effective.
Paperback / softback
€182.99
Published August, 2016
By Alfred Langler, Patrick J. Mansky and Georg Seifert
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available
By Alfred Langler, Patrick J. Mansky and Georg Seifert
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available
This book covers a broad spectrum of complementary and alternative medicine (CAM) practices employed in pediatric oncology worldwide, with a special focus on the methods widely used in Western countries.
Paperback / softback
€128.71
Published August, 2016
By Faruque Riffat, Carsten E. Palme and Michael Veness
Publisher: Springer (Springer, India, Private Ltd)
Rating:
Availability: Available
By Faruque Riffat, Carsten E. Palme and Michael Veness
Publisher: Springer (Springer, India, Private Ltd)
Rating:
Availability: Available
However, the spectrum of presentations and subsequent management varies widely, ranging from patients with the ubiquitous low-risk mid-face basal cell carcinoma to those diagnosed with relatively uncommon but potentially life-threatening high-risk squamous cell carcinomas (e.g.
Paperback / softback
€97.59